MARKET

XGN

XGN

Exagen Inc.
NASDAQ
7.20
-0.29
-3.87%
After Hours: 7.20 0 0.00% 16:10 12/05 EST
OPEN
7.50
PREV CLOSE
7.49
HIGH
7.58
LOW
7.18
VOLUME
149.77K
TURNOVER
--
52 WEEK HIGH
12.23
52 WEEK LOW
2.670
MARKET CAP
163.17M
P/E (TTM)
-7.7779
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XGN last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at XGN last week (1117-1121)?
Weekly Report · 11/24 09:16
Exagen’s Strategic Growth and Innovation Drive Buy Rating Amid Market Expansion
TipRanks · 11/18 11:55
Weekly Report: what happened at XGN last week (1110-1114)?
Weekly Report · 11/17 09:16
Exagen management to meet virtually with B. Riley
TipRanks · 11/14 15:50
Exagen Inc. to Participate in Craig-Hallum Alpha Select Conference
Reuters · 11/11 14:00
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Barchart · 11/11 08:00
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Exagen (XGN), Zimmer Biomet Holdings (ZBH) and Pelthos Therapeutics (PTHS)
TipRanks · 11/10 12:31
More
About XGN
Exagen Inc. is a provider of autoimmune diagnostics focused on transforming care for patients with chronic and debilitating autoimmune conditions. The Company is focused on the design, development and commercialization of a portfolio of testing products under its AVISE brand, which allow for the differential diagnosis, prognosis and monitoring of complex rheumatic, autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its testing products are supported by two proprietary technologies: its AVISE Lupus platform, which incorporates Cell-Bound Complement Activation Products (CB-CAPs) for diagnosing SLE, and a set of three biomarkers, the t-cell-based CB-CAP TC4d, along with two t-cell antibodies, TIgG, and TIgM (the T-Cell Biomarkers), all of which are incorporated into its AVISE CTD product. The Company’s flagship product, AVISE CTD, enables clinicians to more effectively diagnose complex autoimmune conditions.

Webull offers Exagen Inc stock information, including NASDAQ: XGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XGN stock methods without spending real money on the virtual paper trading platform.